140 related articles for article (PubMed ID: 6682104)
21. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ
Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
[No Abstract] [Full Text] [Related]
22. Drug resistance induction and cross-resistance studies with Pt-complexes.
Hrubisko M; Balázová E; Ujházy V
Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
[TBL] [Abstract][Full Text] [Related]
24. [Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy].
Uhl J; Langrock K; Krieghoff B; Hambsch K
Radiobiol Radiother (Berl); 1987; 28(1):51-7. PubMed ID: 3588859
[No Abstract] [Full Text] [Related]
25. In vivo and in vitro effectivity of some platinum complexes.
Balázová E; Hrubisko M; Ujházy V
Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
[TBL] [Abstract][Full Text] [Related]
26. [A new antitumor compound: hydroxy-9 ellipticin. Effect on mouse L 1210 leukemia].
Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
C R Acad Hebd Seances Acad Sci D; 1973 Nov; 277(20):2289-91. PubMed ID: 4211276
[No Abstract] [Full Text] [Related]
27. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
[TBL] [Abstract][Full Text] [Related]
28. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
Graczyk J; Pakulska W; Groszkowski S; Najman L
Acta Pol Pharm; 1980; 37(2):249-54. PubMed ID: 7468274
[No Abstract] [Full Text] [Related]
29. Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine.
Maral R; Bourut C; Chenu E; Mathé G
Cancer Lett; 1984 Feb; 22(1):49-54. PubMed ID: 6697321
[TBL] [Abstract][Full Text] [Related]
30. Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
Sava G; Zorzet S; Giraldi T; Mestroni G; Zassinovich G
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):841-7. PubMed ID: 6540184
[TBL] [Abstract][Full Text] [Related]
31. [Antitumor and immunodepressive action of dexamethasone on a leukemia L-1210 model].
Berezina TA; Uteshev BS; Babichev VS
Farmakol Toksikol; 1979; 42(5):537-41. PubMed ID: 488332
[TBL] [Abstract][Full Text] [Related]
32. Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
Alama A; Tasso B; Novelli F; Sparatore F
Drug Discov Today; 2009 May; 14(9-10):500-8. PubMed ID: 19429510
[TBL] [Abstract][Full Text] [Related]
33. Alkylphosphonium salts as a new class of antitumor agents.
Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
[TBL] [Abstract][Full Text] [Related]
34. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
Goncharova SA; Minenkova EA; Fomina MM; Demidova NS
Eksp Onkol; 1984; 6(4):38-41. PubMed ID: 6499750
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
36. New tumor-inhibiting metal complexes.
Keppler BK; Berger MR; Heim ME
Cancer Treat Rev; 1990 Sep; 17(2-3):261-77. PubMed ID: 2272042
[No Abstract] [Full Text] [Related]
37. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):73-8. PubMed ID: 2404458
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
Anderson WK; Quagliato DA; Haugwitz RD; Narayanan VL; Wolpert-DeFilippes MK
Cancer Treat Rep; 1986 Aug; 70(8):997-1002. PubMed ID: 3731155
[TBL] [Abstract][Full Text] [Related]
39. Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
J Cancer Res Clin Oncol; 1994; 120(10):571-7. PubMed ID: 7929527
[TBL] [Abstract][Full Text] [Related]
40. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.
Köpf-Maier P; Wagner W; Liss E
J Cancer Res Clin Oncol; 1981; 102(1):21-30. PubMed ID: 7199526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
